Unknown

Dataset Information

Maternal-to-zygotic transition as a potential target for niclosamide during early embryogenesis.


ABSTRACT: Niclosamide is an antihelminthic drug used worldwide for the treatment of tapeworm infections. Recent drug repurposing screens have highlighted the broad bioactivity of niclosamide across diverse mechanisms of action. As a result, niclosamide is being evaluated for a range of alternative drug-repurposing applications, including the treatment of cancer, bacterial infections, and Zika virus. As new applications of niclosamide will require non-oral delivery routes that may lead to exposure in utero, it is important to understand the mechanism of niclosamide toxicity during early stages of embryonic development. Previously, we showed that niclosamide induces a concentration-dependent delay in epiboly progression in the absence of effects on oxidative phosphorylation - a well-established target

SUBMITTER: Vliet SMF 

PROVIDER: S-EPMC6717554 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature